Ara
Toplam kayıt 5, listelenen: 1-5
Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome
(Taylor & Francis Ltd, 2014)
We aimed to investigate whether overweight/obesity is associated with omentin and chemerin. The study group consisted of 81 women with Polycystic ovarian syndrome (PCOS) (41 lean, BMI<25 kg/m(2) and 40 overweight or obese, ...
Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
(Taylor & Francis Ltd, 2012)
We aimed to analyze lipid parameters and determine the need for a 2-hour oral glucose tolerance test (OGTT) for the identification of IR and impaired glucose tolerance test (IGT) in subclinical hypothyroidism (SCH) women ...
Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study
(Elsevier Science Inc, 2014)
Objective: To investigate whether retesting with the oral glucose tolerance test (OGTT) is useful and necessary for all women with polycystic ovary syndrome ( PCOS). Design: Follow-up study. Setting: Tertiary medical center. ...
Assessment of impaired glucose tolerance prevalence with hemoglobin A(1c) and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study
(Oxford Univ Press, 2013)
What is the prevalence of abnormalities in glucose metabolism in patients with polycystic ovary syndrome (PCOS) and controls in a Turkish population? The total prevalence of glucose abnormalities in PCOS patients was 16.3 ...
Implications of circulating irisin and Fabp4 levels in patients with polycystic ovary syndrome
(Taylor & Francis Inc, 2016)
The aim of the study was to evaluate the fatty acid-binding protein-4 (FABP4) and irisin concentrations in women with polycystic ovary syndrome (PCOS). Forty-nine women with PCOS, diagnosed according to Rotterdam criteria ...